How many Gokhale Method outlets were operating in New York at the end of 2023?
Gokhale_Method Franchise · 2024 FDDAnswer from 2024 FDD Document
021 to 2023
| State | Year | Outletsat Startof Year | Outlets Opened | Terminatio ns | Non Renewals | Reacquired by Franchisor | Ceased Operations Other Reasons | Outletsat Endofthe Year |
|---|---|---|---|---|---|---|---|---|
| Alabama | 2021 | 1 | 0 | 0 | 0 | 0 | 0 | 1 |
| 2022 | 1 | 0 | 0 | 0 | 0 | 0 | 1 | |
| 2023 | 1 | 0 | 0 | 0 | 0 | 0 | 1 | |
| California | 2021 |
Source: Item 20 — OUTLETS AND FRANCHISEE REPRESENTATIONS (FDD pages 30–34)
What This Means (2024 FDD)
According to Gokhale Method's 2024 Franchise Disclosure Document, there was one outlet operating in New York at the end of 2023. The table provided in Item 20 of the FDD details the status of franchised outlets for the years 2021 to 2023, broken down by state. This table shows the changes in the number of outlets in each state due to openings, terminations, non-renewals, re acquisitions by the franchisor, and other reasons for ceasing operations.
For a prospective franchisee, this information is valuable in understanding the brand's presence and performance in specific geographic areas. The data indicates the stability and growth (or decline) of Gokhale Method outlets in New York, which can inform their decision-making process. Seeing the changes over the three-year period provides a clearer picture than just a single year's snapshot.
It is important to note that while the table provides a detailed overview, it does not offer specific reasons for the changes in outlet numbers. For instance, in New York, the table shows a decrease from two outlets to one in 2023 due to 'Ceased Operations Other Reasons'. A potential franchisee might want to investigate the reasons behind such changes to better assess the risks and opportunities associated with opening a Gokhale Method franchise in that area. This information, combined with other factors like market demographics and competition, can contribute to a more informed investment decision.